TwycrossRBarkbyGHallywoodP. The use of low dose levomepromazine (methotrimeprazine) in the management of nausea and vomiting. Progr Palliat Care1997; 5: 49–53.
2.
DreizenS. Oral indications of the deficiency states. Postgrad Med1971; 54: 97–102.
3.
SilvermanSJr. Diagnosis and treatment of commonly occurring mucosal lesions. In: MitchellDF (ed) Dental clinics of North America. Philadelphia: WB Saunders, 1968, pp. 111–123.
4.
BartelinkA. Drug-induced diseases of the gastrointestinal tract. In: MeylerLMPeckHM (eds) Drug-induced diseases. Amsterdam: Excerpta Medica, 1972, pp. 403–407.
5.
EisenchlasJGarrigueNJuninMDe SimoneG. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliat Med2005; 19: 71–75.
6.
GreenBPettitTFaithL. Focus on levomepromazine. Curr Med Res Opin2004; 20(4): 1877–1881.
7.
LeibovitchGMaaraviYShalevO. Severe facial oedema and glossitis associated with mianserin. Lancet1989; 2(8667): 871–872.
8.
de la FuenteJBerlangaC. Glossitis associated with mianserin. Lancet1988; 1(8370): 233–234.
